| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |